Parikh Alomi O, Conger Jordan R, Sibug Saber Maria E, Samimi David, Burnstine Michael A
USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.
Eyesthetica, Los Angeles, California.
Ophthalmic Plast Reconstr Surg. 2023;39(4):366-369. doi: 10.1097/IOP.0000000000002323. Epub 2023 Feb 2.
To present a case of facial disfigurement from an injectable permanent filler and describe the consequences to patients exposed to the same injector (common source outbreak).
Case report and discussion of a common source outbreak after a group of persons developed complications years after permanent filler given by one injector.
A 39-year-old transgender model underwent polymethylmethacrylate (Artefill) facial filler injections to the lips, cheeks, and chin in 2018. A year later, the patient presented to the emergency room with severe facial swelling and difficulty breathing. Treatments have included 4 surgeries to remove filler and scar tissue and chronic low-dose oral steroid therapy. Upon questioning the patient, 6 additional people suffered from similar facial swelling years after injection by the same injector. The injector cannot be located.
Care must be taken in giving all facial fillers, particularly permanent ones. When one source patient is identified, questioning the patient's knowledge of others affected is critical to help manage an epidemic problem and to report a rogue injector. Physicians have a duty to investigate and report such cases.
介绍一例因注射永久性填充剂导致面部毁容的病例，并描述同一注射者（共同来源暴发）给患者带来的后果。
病例报告及对一组人员在接受同一注射者注射永久性填充剂数年之后出现并发症这一共同来源暴发情况的讨论。
一名39岁的变性模特于2018年接受了聚甲基丙烯酸甲酯（爱贝芙）面部填充剂注射，注射部位为嘴唇、脸颊和下巴。一年后，该患者因面部严重肿胀和呼吸困难前往急诊室就诊。治疗措施包括4次手术以取出填充剂和瘢痕组织，以及长期低剂量口服类固醇治疗。经询问该患者得知，另有6人在接受同一注射者注射数年之后也出现了类似的面部肿胀情况。目前无法找到该注射者。
在使用所有面部填充剂时，尤其是永久性填充剂时，必须谨慎。当识别出一名源头患者时，询问该患者对其他受影响者的了解情况对于控制疫情问题以及举报违规注射者至关重要。医生有责任调查并报告此类病例。
